twarde
Sponsors
Medical University Of Lodz, Medical University Of Warsaw, Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy, Instytut Psychiatrii I Neurologii
Conditions
Attention-deficit hyperactivity disorderChildren primary nephropathy IgACrohn's diseaseMultiple sclerosisNeurodegeneration with brain iron accumulation (NBIA)Type 1 diabetesincluding pantothenate kinase-associated neurodegeneration (PKAN) and mitochondrial membrane protein-associated neurodegeneration (MPAN).
Phase 2
LAMAinDiab - lisdexamphetamine vs methylphenidate for pediatric patients with ADHD and type 1 diabetes - a randomized crossover clinical trial.
Active, not recruitingCTIS2023-506862-30-00
Start: 2024-11-24Target: 150Updated: 2025-08-25
PRObiotic Therapy Examining Combinatorial Therapeutics in Multiple Sclerosis - phase II, multicenter, randomised, open-label clinical trial.
WithdrawnCTIS2025-520955-10-00
Target: 210Updated: 2025-10-20
Phase 2, randomized, blinded, non-treatment-controlled study assessing the efficacy and safety of dimethyl fumarate in patients with NBIA, a neurodegeneration associated with brain iron accumulation.
WithdrawnCTIS2026-525990-38-00
Target: 40Updated: 2026-09-07
Phase 3
Evaluation of the efficacy of topical treatment with budesonide in children with Crohn's disease located in the esophagus and/or stomach and/or duodenum - BETHESDa
RecruitingCTIS2024-519269-23-00
Start: 2024-03-27Target: 138Updated: 2025-07-10
SABINE - The efficacy and Safety of delayed-release Budesonide in children with primary IgA nephropathy - a multicenter, interventional phase III, randomized, placebo-controlled, double-blind study.
Not yet recruitingCTIS2024-518759-45-00
Target: 120Updated: 2025-11-25